Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.750
0.00 (0.00%)
Mar 9, 2026, 4:00 PM EDT - Market closed
ZYBT Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 153.74 | 186.36 | 211.65 | 260.27 | 214.07 |
| Revenue Growth (YoY) | -18.98% | -11.95% | -18.68% | 21.58% | - |
| Cost of Revenue | 96.28 | 95.06 | 94.14 | 112.39 | 89.45 |
| Gross Profit | 57.46 | 91.3 | 117.51 | 147.88 | 124.62 |
| Selling, General & Admin | 69.95 | 63.84 | 64.34 | 58.89 | 58.86 |
| Research & Development | 16.32 | 12.79 | 11.9 | 13.42 | 11.37 |
| Operating Expenses | 84.81 | 74.86 | 72.52 | 82.05 | 72.16 |
| Operating Income | -27.35 | 16.44 | 44.99 | 65.83 | 52.47 |
| Interest Expense | -3.74 | -4.04 | -4.42 | -2.84 | -1.05 |
| Interest & Investment Income | 0.09 | 0.23 | 0.31 | 0.11 | 0.11 |
| Currency Exchange Gain (Loss) | -0.74 | 0.68 | - | - | - |
| Other Non Operating Income (Expenses) | 1.97 | 1.09 | 2.89 | 0.81 | 1.62 |
| EBT Excluding Unusual Items | -29.78 | 14.39 | 43.76 | 63.91 | 53.15 |
| Asset Writedown | - | - | - | - | -0.08 |
| Pretax Income | -29.78 | 14.39 | 43.76 | 63.91 | 53.07 |
| Income Tax Expense | -6.97 | 0.92 | 6.25 | 8.17 | 6.6 |
| Earnings From Continuing Operations | -22.81 | 13.47 | 37.51 | 55.74 | 46.47 |
| Minority Interest in Earnings | 3.44 | -2.16 | -6.05 | -9.01 | -7.51 |
| Net Income | -19.37 | 11.31 | 31.46 | 46.74 | 38.96 |
| Net Income to Common | -19.37 | 11.31 | 31.46 | 46.74 | 38.96 |
| Net Income Growth | - | -64.04% | -32.69% | 19.96% | - |
| Shares Outstanding (Basic) | 46 | 46 | 46 | 46 | 46 |
| Shares Outstanding (Diluted) | 46 | 46 | 46 | 46 | 46 |
| EPS (Basic) | -0.42 | 0.25 | 0.69 | 1.02 | 0.85 |
| EPS (Diluted) | -0.42 | 0.25 | 0.69 | 1.02 | 0.85 |
| EPS Growth | - | -64.04% | -32.69% | 19.96% | - |
| Free Cash Flow | 0.31 | 27.46 | 40.79 | -9.99 | 12.75 |
| Free Cash Flow Per Share | 0.01 | 0.60 | 0.89 | -0.22 | 0.28 |
| Gross Margin | 37.37% | 48.99% | 55.52% | 56.82% | 58.22% |
| Operating Margin | -17.79% | 8.82% | 21.25% | 25.30% | 24.51% |
| Profit Margin | -12.60% | 6.07% | 14.86% | 17.96% | 18.20% |
| Free Cash Flow Margin | 0.20% | 14.74% | 19.27% | -3.84% | 5.96% |
| EBITDA | -2.21 | 40.6 | 68.9 | 84.63 | 68.48 |
| EBITDA Margin | -1.44% | 21.79% | 32.55% | 32.52% | 31.99% |
| D&A For EBITDA | 25.14 | 24.16 | 23.91 | 18.8 | 16.01 |
| EBIT | -27.35 | 16.44 | 44.99 | 65.83 | 52.47 |
| EBIT Margin | -17.79% | 8.82% | 21.25% | 25.29% | 24.51% |
| Effective Tax Rate | - | 6.42% | 14.29% | 12.79% | 12.44% |
| Advertising Expenses | - | 1.54 | 2.54 | 2.58 | 2.23 |
Source: S&P Capital IQ. Standard template. Financial Sources.